Emerald Bioscience to Present at Cowen 2nd Annual Boston Cannabis Conference
04 nov. 2019 08h30 HE
|
Emerald Bioscience, Inc.
LONG BEACH, CA, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications,...
Emerald Bioscience to Present at the 9th Annual LD Micro Invitational
03 juin 2019 08h00 HE
|
Emerald Bioscience, Inc.
LONG BEACH, CA, June 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to...
Nemus Bioscience Signs Agreement with Noramco to Manufacture Proprietary Cannabidiol Analog
04 mars 2019 07h30 HE
|
Nemus Bioscience, Inc.
Enhanced Bioavailability Could Prove Pivotal in Providing Neuroprotection in Diseases of the Retina LONG BEACH, CA, March 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc....
Nemus Bioscience to Present at the NobleCon XV and 8th Annual Glaucoma 360 New Horizons Forum
23 janv. 2019 07h30 HE
|
Nemus Bioscience, Inc.
LONG BEACH, CA, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to...
NEMUS Bioscience to Present at The MicroCap Conference
26 sept. 2018 08h00 HE
|
Nemus Bioscience, Inc.
LONG BEACH, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical...